Drug-induced interstitial lung disease in molecular targeted therapies: high-resolution CT findings
- 10 November 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in International Journal of Clinical Oncology
- Vol. 17 (6), 542-550
- https://doi.org/10.1007/s10147-012-0489-2
Abstract
Drug-induced lung injury (DLI) comprises a wide variety of pathologies, each with a unique imaging pattern, so there are no characteristic imaging findings to establish diagnosis. When DLI is suspected, evaluation must exclude progression of underlying disease, infection, and mimicking diseases. Correct diagnosis requires integration of clinical information and radiologic, laboratory, and pathological findings when available. We describe the radiologic findings of DLI, the roles of the findings in the management of patients with DLI, and the limitations of radiologic diagnosis.Keywords
This publication has 31 references indexed in Scilit:
- Tacrolimus-induced pulmonary injury in rheumatoid arthritis patientsPulmonary Pharmacology & Therapeutics, 2011
- Drug-Induced Hypersensitivity SyndromeMedicine, 2009
- Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: A retrospective review and case–control study of 21 patientsArthritis Care & Research, 2009
- Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylateLeukemia, 2006
- Interstitial Lung Disease Induced by Drugs and RadiationRespiration, 2004
- Drug-induced Lung Disease: High-resolution CT and Histological FindingsClinical Radiology, 2002
- Drug-induced lung injurySeminars in Roentgenology, 2002
- Bronchiolitis obliterans organising pneumonia associated with the use of nitrofurantoinThorax, 2000
- Amiodarone pulmonary toxicity. Clinical, radiologic, and pathologic correlationsArchives of Internal Medicine, 1987
- CT Demonstration of High Attenuation Pleural-Parenchymal Lesions Due to Amiodarone TherapyJournal of Computer Assisted Tomography, 1987